Diathesis Liquid
NDC Package 43857-0372-1
Package Information
Diathesis (germanium sesquioxide, cuprum metallicum, manganum metallicum, intestine (suis), lung (suis), cysteinum, manganese gluconate, alpha-ketoglutaricum acidum, arsenicum album, calcarea carbonica, fumaricum acidum, natrum oxalaceticum, phosphorus) liquids is for temporary relief of inflammation of bones or joints, with nightly digging pains, general soreness & aching, spasmodic states such as intestinal colic, cramps of calf muscles, & spasmodic coughing. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0372.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- COPPER 8 [hp_X]/mL
- CYSTEINE 9 [hp_X]/mL
- FUMARIC ACID 12 [hp_X]/mL
- GERMANIUM SESQUIOXIDE 8 [hp_X]/mL
- MANGANESE 8 [hp_X]/mL
- MANGANESE GLUCONATE 10 [hp_X]/mL
- OXOGLURIC ACID 12 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- PORK INTESTINE 8 [hp_X]/mL
- SODIUM DIETHYL OXALACETATE 12 [hp_X]/mL
- SUS SCROFA LUNG 8 [hp_X]/mL
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc.
- 43857-0372 - Diathesis
- 43857-0372-1 - 30 mL in 1 BOTTLE, DROPPER
- 43857-0372 - Diathesis
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0372-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Diathesis II, a human over the counter drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains arsenic trioxide; copper; cysteine; fumaric acid; germanium sesquioxide; manganese; manganese gluconate; oxogluric acid; oyster shell calcium carbonate, crude; phosphorus; pork intestine; sodium diethyl oxalacetate; sus scrofa lung as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on July 09, 2015. The current certification is valid through December 31, 2026.
How is this Bioactive Nutritional, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857037201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.